Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
Actual shortage: | 218 (6%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 335 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2017-09-26 | 2018-01-18 | 23553 |
APO-FAMCICLOVIR | 125MG | TABLET | Resolved | 2017-10-23 | 2018-01-19 | 26572 |
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2023-01-06 | 2023-02-09 | 180116 |
APO-FAMCICLOVIR | 125MG | TABLET | Resolved | 2022-04-08 | 2022-05-13 | 158353 |
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2022-07-15 | 2022-09-23 | 164701 |
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2018-07-11 | 2018-08-09 | 55276 |
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2018-09-04 | 2018-12-18 | 59816 |
APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2023-12-08 | 2024-01-19 | 212955 |
APO-FAMOTIDINE | 10MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19048 |
APO-FAMOTIDINE TAB 20MG USP | 20 MG | TABLET | Resolved | 2017-03-11 | 2018-09-09 | 619 |
APO-FAMOTIDINE TAB 40MG USP | 40MG | TABLET | Resolved | 2017-03-11 | 2018-09-09 | 616 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-08-08 | 2017-09-22 | 18543 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-10-16 | 2019-11-18 | 96647 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-19 | 2024-02-09 | 216662 |
APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-21 | 2023-08-04 | 199527 |
APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-17 | 2024-02-02 | 210689 |
APO-FELODIPINE | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-24 | 2024-02-09 | 211484 |
APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-08-15 | 2024-10-11 | 235345 |
APO-FELODIPINE | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-09-12 | 2024-10-11 | 237378 |
APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-11 | 2018-08-01 | 55299 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-LEVOCARB | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
APO-LOSARTAN | 50MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 60987 |
APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |